The (-)-deprenyl actions on beta-adrenergic receptors require the integrity of brain serotonergic axon terminals.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  European Journal of Pharmacology

• Publication date

  1984-04-20

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-2999(84)90229-2PMID 6329776
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• On the mode of action of imipramine: relationship between serotonergic axon terminal function and down-regulation of beta-adrenergic receptors.

  1983cited by this paper
• [3H]imipramine binding in subcellular fractions of rat cerebral cortex after chemical lesion of serotonergic neurons.

  1983cited by this paper
• (-)-Deprenyl a selective MAO "B' inhibitor, increases [3H]imipramine binding and decreases beta-adrenergic receptor function.

  1983cited by this paper
• Different synaptic location of mianserin and imipramine binding sites.

  1982cited by this paper
• Does the B form selective monoamine oxidase inhibitor lose selectivity by long term treatment?

  1979cited by this paper
• The noradrenergic cyclic AMP generating system in the limbic forebrain: pharmacological characterization in vitro and possible role of limbic noradrenergic mechanisms in the mode of action of antipsychotics.

  1976cited by this paper
• Radioimmunoassay for cyclic nucleotides. II. Adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in mammalian tissues and body fluids.

  1972cited by this paper

• Animal models of depression in drug discovery: a historical perspective.

  2006cites this paper
• Clinical investigation of monoamine neurotransmitter interactions

  2005cites this paper
• Reversal of stress-induced deficit in aggression by monoamine oxidase inhibitors.

  1999cites this paper
• Brain monoamine oxidase and aging: a review.

  1992cites this paper
• [Brain monoamine oxidase and its inhibitors in gerontology (review of the literature)].

  1988cites this paper
• MODULATION OF NEUROTRANSMITTER RECEPTORS AND DRUG RECOGNITION SITES BY REPEATED DOSES OF (-)DEPRENYL

  1986cites this paper
• Maprotiline: an antidepressant with an unusual pharmacological profile.

  1986cites this paper
• Chronic antidepressant treatment and mouse brain 3H‐imipramine binding

  1986cites this paper
• Desipramine-yohimbine combination treatment of refractory depression. Implications for the beta-adrenergic receptor hypothesis of antidepressant action.

  1986cites this paper
• The effect of repeated doses of (-) deprenyl on the dynamics of monoaminergic transmission. Comparison with clorgyline.

  1986cites this paper